BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 9697002)

  • 21. [Gene therapy for brain tumors: strategy utilizing herpes simplex virus type 1].
    Inoue R; Fujiki M; Kobayashi H
    No Shinkei Geka; 2008 Mar; 36(3):265-76. PubMed ID: 18341016
    [No Abstract]   [Full Text] [Related]  

  • 22. Radiation-inducible caspase-8 gene therapy for malignant brain tumors.
    Tsurushima H; Yuan X; Dillehay LE; Leong KW
    Int J Radiat Oncol Biol Phys; 2008 Jun; 71(2):517-25. PubMed ID: 18407431
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vivo efficacy and toxicity of 5-fluorocytosine/cytosine deaminase gene therapy for malignant gliomas mediated by adenovirus.
    Ichikawa T; Tamiya T; Adachi Y; Ono Y; Matsumoto K; Furuta T; Yoshida Y; Hamada H; Ohmoto T
    Cancer Gene Ther; 2000 Jan; 7(1):74-82. PubMed ID: 10678359
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genetic strategies for brain tumor therapy.
    Lawler SE; Peruzzi PP; Chiocca EA
    Cancer Gene Ther; 2006 Mar; 13(3):225-33. PubMed ID: 16138122
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Gene transduction for experimental brain tumors using recombinant adenovirus vector].
    Ichikawa T; Tamiya T; Adachi Y; Ono Y; Matsumoto K; Furuta T; Ohmoto T; Yoshida Y; Hamada H
    No To Shinkei; 1998 Aug; 50(8):731-8. PubMed ID: 9757466
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cationic albumin-conjugated pegylated nanoparticles allow gene delivery into brain tumors via intravenous administration.
    Lu W; Sun Q; Wan J; She Z; Jiang XG
    Cancer Res; 2006 Dec; 66(24):11878-87. PubMed ID: 17178885
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A tale of two trials: selectively replicating herpesviruses for brain tumors.
    Kirn DH
    Gene Ther; 2000 May; 7(10):815-6. PubMed ID: 10845717
    [No Abstract]   [Full Text] [Related]  

  • 28. Intratumoral gene therapy of malignant brain tumor in a rat model with angiostatin delivered by adeno-associated viral (AAV) vector.
    Ma HI; Lin SZ; Chiang YH; Li J; Chen SL; Tsao YP; Xiao X
    Gene Ther; 2002 Jan; 9(1):2-11. PubMed ID: 11850717
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Radio-responsive TRAIL gene therapy for malignant gliomas.
    Kyritsis AP; Rao JS; Puduvalli VK
    Cancer Gene Ther; 2007 Dec; 14(12):1002. PubMed ID: 17704752
    [No Abstract]   [Full Text] [Related]  

  • 30. Adenovirus-mediated herpes simplex virus thymidine kinase gene therapy in BT4C rat glioma model.
    Tyynelä K; Sandmair AM; Turunen M; Vanninen R; Vainio P; Kauppinen R; Johansson R; Vapalahti M; Ylä-Herttuala S
    Cancer Gene Ther; 2002 Nov; 9(11):917-24. PubMed ID: 12386830
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Endothelial progenitor cells' "homing" specificity to brain tumors.
    Moore XL; Lu J; Sun L; Zhu CJ; Tan P; Wong MC
    Gene Ther; 2004 May; 11(10):811-8. PubMed ID: 15057261
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Normal brain cells contribute to the bystander effect in suicide gene therapy of malignant glioma.
    Miletic H; Fischer YH; Giroglou T; Rueger MA; Winkeler A; Li H; Himmelreich U; Stenzel W; Jacobs AH; von Laer D
    Clin Cancer Res; 2007 Nov; 13(22 Pt 1):6761-8. PubMed ID: 18006778
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intra-arterial delivery of endostatin gene to brain tumors prolongs survival and alters tumor vessel ultrastructure.
    Barnett FH; Scharer-Schuksz M; Wood M; Yu X; Wagner TE; Friedlander M
    Gene Ther; 2004 Aug; 11(16):1283-9. PubMed ID: 15164099
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Changing boundaries in the treatment of malignant gliomas.
    Brandes AA; Basso U; Pasetto LM
    Expert Rev Anticancer Ther; 2001 Oct; 1(3):357-70. PubMed ID: 12113103
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oligodendroglial tumors.
    Chowdhary S; Chamberlain MC
    Expert Rev Neurother; 2006 Apr; 6(4):519-32. PubMed ID: 16623651
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sitimagene ceradenovec, a gene therapeutic for the treatment of glioma.
    Düzgünes N
    Curr Opin Mol Ther; 2008 Apr; 10(2):187-95. PubMed ID: 18386231
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Induction of immunity in peripheral tissues combined with intracerebral transplantation of interleukin-2-producing cells eliminates established brain tumors.
    Iwadate Y; Yamaura A; Sato Y; Sakiyama S; Tagawa M
    Cancer Res; 2001 Dec; 61(24):8769-74. PubMed ID: 11751397
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Gene therapy of glioblastoma].
    Astrup J
    Ugeskr Laeger; 2001 Apr; 163(15):2147. PubMed ID: 11332215
    [No Abstract]   [Full Text] [Related]  

  • 39. Transduction of thymidine phosphorylase cDNA facilitates efficacy of cytosine deaminase/5-FC gene therapy for malignant brain tumor.
    Manome Y; Watanabe M; Abe T; Tomita M; Watanabe S; Yokokawa Y; Takahashi Y; Ishii K; Kimura A; Murakami M; Nagata M; Shibata T; Nakamura M; Tanigawa N; Ohno T
    Anticancer Res; 2001; 21(4A):2265-72. PubMed ID: 11724281
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Human gene therapy].
    Ylä-Herttuala S; Ollikainen A; Vapalahti M
    Duodecim; 1996; 112(2):77-9. PubMed ID: 10590609
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.